Evidence map›Paper›PMID 24714445›Full record

ArticleSexually transmitted infections2014

Uptake of prevention of mother-to-child-transmission using Option B+ in northern rural Malawi: a retrospective cohort study.

Alison J Price, Michael Kayange, Basia Zaba, Frank M Chimbwandira, Andreas Jahn, Zengani Chirwa, Aisha Nz Dasgupta, Cynthia Katundu, Jacqueline L Saul, Judith R Glynn and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Sexually transmitted infections, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 3 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 3 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Alison J PriceLondon School of Hygiene and Tropical Medicine, London, UK.
Michael KayangeMalawi Ministry of Health, Lilongwe, Malawi.
Basia ZabaLondon School of Hygiene and Tropical Medicine, London, UK.
Frank M ChimbwandiraMalawi Ministry of Health, Lilongwe, Malawi.
Andreas JahnMalawi Ministry of Health, Lilongwe, Malawi.
Zengani ChirwaMalawi Ministry of Health, Lilongwe, Malawi.
Aisha Nz DasguptaLondon School of Hygiene and Tropical Medicine, London, UK.
Cynthia KatunduKaronga Prevention Study, Chilumba, Malawi.
Jacqueline L SaulLondon School of Hygiene and Tropical Medicine, London, UK.
Judith R GlynnLondon School of Hygiene and Tropical Medicine, London, UK.
Olivier KooleLondon School of Hygiene and Tropical Medicine, London, UK.
Amelia C CrampinLondon School of Hygiene and Tropical Medicine, London, UK.
London School of Hygiene & Tropical Medicine · GBMinistry of Health · MWMalawi Epidemiology and Intervention Research Unit · MW

Funding

Wellcome Trust 096249/Z/11/AWellcome Trust 098610
6 · The paper itself

Abstract

To identify points of dropout on the pathway from offering HIV testing to maintenance on antiretroviral therapy (ART), following the introduction of the Option B+ policy for pregnant women in Malawi (lifelong ART for HIV-positive mothers and 6 weeks nevirapine for the infants), a retrospective cohort study within a demographic surveillance system in northern Malawi. Women living in the demographic surveillance system who initiated antenatal care (ANC) between July 2011 (date of policy change) and January 2013, were eligible for inclusion. Women who consented were interviewed at home about their health facility attendance and care since pregnancy, including antenatal clinic (ANC) visits, delivery and postpartum care. Women's reports, patient-held health records and clinic health records were manually linked to ascertain service use. Among 395 women, 86% had tested for HIV before the pregnancy, 90% tested or re-tested at the ANC visit, and <1% had never tested. Among 53 mothers known to be HIV-positive before attending ANC, 15 (28%) were already on ART prior to pregnancy. Ten women tested HIV-positive for the first time during pregnancy. Of the 47 HIV-positive mothers not already on ART, 26/47 (55%) started treatment during pregnancy. All but five women who started ART were still on treatment at the time of study interview. HIV testing was almost universal and most women who initiated ART were retained in care. However, nearly half of eligible pregnant women not on ART at the start of ANC had not taken up the invitation to initiate (lifelong) ART by the time of delivery, leaving their infants potentially HIV-exposed.

Indexed as

AdenineAdultAlkynesAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveBenzoxazinesChemopreventionCohort StudiesCyclopropanesFemaleHIV InfectionsHumansInfant, NewbornInfectious Disease Transmission, VerticalLamivudineMalawiAdenineAlkynesAnti-HIV AgentsBenzoxazinesCyclopropanesefavirenzLamivudineNevirapineOrganophosphonatesTenofovirANTENATAL HIVCHILDRENPREVENTION

Identifiers

PMID24714445
PMCPMC4033143
OpenAlexW2171697148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.